(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions (Q34110581)

31 July 2017

1 reference

title

(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions (English)

1 reference

31 July 2017

Guo-Zhang Jin

1

1 reference

PubMed ID

11804640

31 July 2017

Zi-Tao Zhu

series ordinal

2

1 reference

PubMed ID

11804640

31 July 2017

Yu Fu

series ordinal

3

1 reference

31 July 2017

1 January 2002

1 reference

Trends in Pharmacological Sciences

31 July 2017

1 reference

31 July 2017

23

1 reference

31 July 2017

1

1 reference

31 July 2017

4-7

1 reference

Dopamine in schizophrenia: a review and reconceptualization

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Dual actions of (-)-stepholidine on dopamine receptor subtypes after substantia nigra lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Atypical neuroleptic properties ofl-stepholidine : Electrophysiological and behavioral studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Modulation of medical prefrontal cortical D1 receptors on the excitatory firing activity of nucleus accumbens neurons elicited by (-)-Stepholidine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

(-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Schizophrenia, the dopamine hypothesis and alpha2-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901929-5

7 January 2021

10.1016/S0165-6147(00)01929-5

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11804640